Vivoryon Therapeutics NV (0R3M) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Jul 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. Announces New Data...
09 Jul 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Host R&D Update...
21 Jun 2024 02:00 PM
GNW
Vivoryon Therapeutics N.V. Reports Outcome o...
23 May 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. Reports Q1 2024 Fi...
15 May 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Report Q1 2024 ...
08 May 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Hold its 2024 A...
24 Apr 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. Reports Full Year ...
16 Apr 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Report Full Yea...
15 Mar 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. Announces Changes ...
04 Mar 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. Provides Update on...
08 Jan 2024 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Host Investor M...
06 Dec 2023 06:00 AM
GNW
Vivoryon Therapeutics N.V. Reports Third Quar...
28 Nov 2023 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Report Q3 2023 ...
07 Sep 2023 06:00 AM
GNW
Vivoryon Therapeutics N.V. Reports H1 2023 Fi...
31 Aug 2023 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Report Half Yea...
04 Aug 2023 10:35 PM
GNW
Vivoryon Therapeutics N.V. Extraordinary Gene...
04 Aug 2023 10:30 PM
GNW
Vivoryon Therapeutics N.V. Announces Proposed...
16 Jul 2023 08:00 AM
GNW
Vivoryon Therapeutics N.V. Shares Clinical De...
21 Jun 2023 05:02 PM
GNW
Vivoryon Therapeutics N.V. Reports Outcome of...
15 Jun 2023 04:49 PM
GNW
Vivoryon Therapeutics N.V. Announces CEO Tran...
01 Jun 2023 06:00 AM
GNW
Vivoryon Therapeutics N.V. to Participate in ...
UK 100